Approval · Notice of Compliance 23916 · 2020
TULAVEN: Notice of Compliance 23916
Issued July 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23916
- Date
- July 16, 2020
- Company
- Ceva Animal Health IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TULAVEN | 02502151 | Marketed |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML